NET PROFIT (x1000 SEK)
EMPLOYEES
Signum Life Science ApS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-4,248
|
-20,057
|
3,833 |
Total assets |
195,711
|
199,767
|
207,624 |
Current assets |
79,323
|
83,218
|
94,895 |
Current liabilities |
19,972
|
18,209
|
20,948 |
Equity capital |
167,861
|
173,341
|
176,671 |
- share capital |
112
![]() |
112
|
103 |
Employees (average) |
35
![]() |
35
![]() |
35 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
85.8%
|
86.8%
|
85.1% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | |||
Current ratio |
397.2%
|
457.0%
|
453.0% |
Return on equity (ROE) |
-2.5%
|
-11.6%
|
2.2% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.